Retina Consultants of America

08/19/2026

This is a classic photo of peripheral exudative hemorrhagic chorioretinopathy (PEHCR), which is when abnormal blood vessels grow and bleed in the peripheral retina. Fortunately for this patient, their disease is not affecting their vision. In more advanced cases, the bleeding can spread to involve the central vision or can cause a vitreous hemorrhage. Oftentimes, observation is sufficient, though advanced cases can benefit from anti-VEGF medications.

08/11/2026

Retina Consultants of Texas explores the emerging field of oculomics and how advanced retinal imaging may provide valuable insights into overall health. Their latest blog explains how technologies like OCT and AI are helping researchers better understand the connection between the retina, the brain, and the cardiovascular system. Learn more: https://brnw.ch/21x4QWF

08/07/2026

Advancing retina care takes both individual expertise and a shared commitment to innovation. Dr. Charles Wykoff of Retina Consultants of Texas reflects on the collaboration that brings physicians together with one common goal: improving outcomes and preserving vision for patients.

08/06/2026

Living with a rare retinal condition often requires highly specialized care. Through our network of leading retina specialists, RCA provides expertise across a wide range of complex retinal diseases, helping connect patients with the specialized care they need.

07/30/2026

This fundus autofluorescence demonstrates a very advanced presentation of macular toxicity from long-term chloroquine usage. Chloroquine is an antimalarial medication that was sometimes used for treating patients with lupus or rheumatoid arthritis. The clumps of hypofluorescent areas with rings of hyperfluorescence suggest significant abnormality of the retinal pigment epithelium, and this patient has likely had irreversible vision loss. While chloroquine is no longer widely used, another related drug, hydroxychloroquine, is routinely used for managing the symptoms of autoimmune diseases. Both drugs are associated with “bull’s eye” toxic maculopathy. Patients taking chloroquine or hydroxychloroquine should be made aware of the potential for adverse effects of long-term use and should have retinal examination to detect early signs of toxicity before symptomatic vision loss has occurred.

07/28/2026

Retina specialist and NASCAR race driver, Dr. Patrick Staropoli of Retina Consultants of Texas, joins the Foundation Fighting Blindness on the latest episode of their Eye on the Cure podcast. Hear how his two careers intersect and how he is using his platform to raise awareness about retinal conditions. Listen to the episode: https://brnw.ch/21x4vl2

07/27/2026

RCA provides its specialists with access to a vast, nationwide research network and the support needed to become a primary investigator. Join a team that values your expertise and connects you with the best practices in the country. Learn more: https://brnw.ch/21x4tkC

07/23/2026

Hearing directly from patients highlights the real impact of retinal care. Robert shares his experience living with macular degeneration and the care he received at Tennessee Retina, reflecting how timely treatment and expert care can help preserve vision.

07/20/2026

Associated Vitreoretinal and Uveitis Consultants explores how anti-VEGF injections help treat retinal conditions caused by abnormal blood vessel growth, including wet macular degeneration, diabetic retinopathy, and retinal vein occlusion. Learn how these treatments help preserve vision and why ongoing care with a retina specialist is important. Learn more: https://brnw.ch/21x4hH2

07/13/2026

This week at , retina specialists across the RCA network will present research — including clinical trial data on real-world evidence — on the latest advances in the management of vitreoretinal diseases.

"The presentations [at ASRS] reflect the breadth, depth, and quality of research being conducted at RCA practices and our shared commitment to advancing novel therapies and management strategies to improve patient outcomes by preserving and improving vision," - Charles C. Wykoff, MD, PhD, FASRS, Director of Research at Retina Consultants of Texas and Chair of Research at RCA.

Learn more about RCA's presence at the American Society of Retina Specialists Annual Meeting: https://brnw.ch/21x461t

Physicians across Retina Consultants of America Network to Present Key Trial Data and Clinical Insights at ASRS 2026